PaO2/FIO2-Based Stratification Discriminates Treatment Failure in Nonintubated Subjects With ARDS.

Background: The new global definition of nonintubated subjects with ARDS can be applied to patients receiving high-flow nasal cannula (HFNC), but stratification with PaO2/FIO2 has not been validated. We aimed to investigate the differences in oxygenation assessment between HFNC and CPAP for predicti...

Descripción completa

Detalles Bibliográficos
Publicado en:Respiratory Care Vol. 71; no. 2; pp. 167 - 176
Autores principales: Sakuraya, Masaaki, Nagata, Kazuma, Yokoyama, Toshiki, Tsugitomi, Ryosuke, Nakashima, Harunori, Kuraishi, Hiroshi, Ohshimo, Shinichiro, Mori, Yoshihiro, Kagami, Ryogo, Tobino, Kazunori, Kamo, Tetsuro, Kadowaki, Toru, Koga, Yasutaka, Ogata, Yoshitaka, Nishimura, Naoki, Kondoh, Yasuhiro, Tomii, Keisuke
Formato: research tables/charts Journal Article
Publicado: Mary Ann Liebert, Inc. Feb2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=191254723&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 191254723
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00201324
        4GG
      jtl: Respiratory Care
      issn: 00201324
      maglogo: N
    pubinfo:
      dt: Feb2026
      vid: 71
      iid: 2
      pid: 1365
      pub: Mary Ann Liebert, Inc.
      place: New Rochelle, New York
    artinfo:
      ui:
        191254723
        191254723
        191254723
        10.1177/19433654251376289
        191254723
      ppf: 167
      ppct: 9
      formats:
      tig:
        atl: PaO2/FIO2-Based Stratification Discriminates Treatment Failure in Nonintubated Subjects With ARDS.
      aug:
        au:
          Sakuraya, Masaaki
          Nagata, Kazuma
          Yokoyama, Toshiki
          Tsugitomi, Ryosuke
          Nakashima, Harunori
          Kuraishi, Hiroshi
          Ohshimo, Shinichiro
          Mori, Yoshihiro
          Kagami, Ryogo
          Tobino, Kazunori
          Kamo, Tetsuro
          Kadowaki, Toru
          Koga, Yasutaka
          Ogata, Yoshitaka
          Nishimura, Naoki
          Kondoh, Yasuhiro
          Tomii, Keisuke
        affil: Dr. Sakuraya is affiliated with Department of Emergency and Intensive Care Medicine, JA Hiroshima General Hospital, Hatsukaichi, Japan.
      sug:
        subj:
          Respiratory Distress Syndrome, Acute Therapy
          Respiration, Artificial Methods
          Oxygen Therapy Methods
          Continuous Positive Airway Pressure Methods
          Treatment Failure
          Human
          Male
          Female
          Aged
          Aged, 80 and Over
          Japan
          Secondary Analysis
          Multicenter Studies
          Randomized Controlled Trials
          Random Assignment
          Post Hoc Analysis
          Anoxemia
          ROC Curve
          Intubation, Intratracheal
          Severity of Illness Indices
          Kruskal-Wallis Test
          Fisher's Exact Test
          Statistical Significance
          Data Analysis Software
          Descriptive Statistics
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: Background: The new global definition of nonintubated subjects with ARDS can be applied to patients receiving high-flow nasal cannula (HFNC), but stratification with PaO2/FIO2 has not been validated. We aimed to investigate the differences in oxygenation assessment between HFNC and CPAP for predicting outcomes. Methods: We performed a post hoc analysis of a multi-center randomized controlled trial conducted in Japan, focusing on oxygenation assessments in subjects receiving HFNC or CPAP. Subjects with PaO2/FIO2 < 300 on CPAP at 5 cm H2O were assigned to receive either HFNC or CPAP. Subjects were stratified into mild (PaO2/FIO2 ≥ 200 but <300), moderate (PaO2/FIO2 ≥ 100 but < 200), or severe (PaO2/FIO2 < 100) hypoxemia categories based on oxygenation levels during CPAP at 5 cm H2O. The primary outcome was treatment failure (intubation or in-hospital death). Discriminative performance for treatment failure was evaluated using the area under the receiver operating characteristic curve (AUROC) for each device. Results: Of the 85 subjects analyzed, 31, 48, and 6 were classified as having mild, moderate, and severe hypoxemia, respectively. Treatment failure occurred more frequently in subjects with moderate and severe hypoxemia than in those with mild hypoxemia (mild 1/31 [3.2%], moderate: 12/48 [25.0%], severe: 3/6 [50.0%], P =.004). Compared with 1 of 38 subjects (2.6%) treated with CPAP, 21 of 47 subjects (44.7%) with HFNC experienced worsened oxygenation even after 30 min of treatment (P <.001). Subjects with HFNC had a lower AUROC of PaO2/FIO2 for treatment failure (0.66, 95% CI 0.54–0.79) than those with CPAP (0.82, 95% CI 0.74–0.90, P =.041). Conclusions: PaO2/FIO2-based stratification may help predict treatment failure in patients with nonintubated subjects with ARDS. However, a thorough oxygenation assessment is necessary because of the variability introduced by different respiratory support devices. CPAP might be superior to HFNC when predicting treatment failure.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N